WELLCOVORIN Drug Patent Profile
✉ Email this page to a colleague
When do Wellcovorin patents expire, and when can generic versions of Wellcovorin launch?
Wellcovorin is a drug marketed by Glaxosmithkline and is included in five NDAs.
The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Wellcovorin
A generic version of WELLCOVORIN was approved as leucovorin calcium by HIKMA on September 14th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for WELLCOVORIN?
- What are the global sales for WELLCOVORIN?
- What is Average Wholesale Price for WELLCOVORIN?
Summary for WELLCOVORIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Clinical Trials: | 97 |
| Patent Applications: | 6,576 |
| DailyMed Link: | WELLCOVORIN at DailyMed |
Recent Clinical Trials for WELLCOVORIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 2 |
| Mayo Clinic | Phase 1 |
| Jonsson Comprehensive Cancer Center | Phase 1/Phase 2 |
US Patents and Regulatory Information for WELLCOVORIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | WELLCOVORIN | leucovorin calcium | INJECTABLE;INJECTION | 089833-001 | Jan 23, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | WELLCOVORIN | leucovorin calcium | TABLET;ORAL | 018342-002 | Jul 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | WELLCOVORIN | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 087439-001 | Oct 19, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | WELLCOVORIN | leucovorin calcium | INJECTABLE;INJECTION | 089465-001 | Jan 23, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | WELLCOVORIN | leucovorin calcium | INJECTABLE;INJECTION | 089834-001 | Jan 23, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | WELLCOVORIN | leucovorin calcium | TABLET;ORAL | 018342-001 | Jul 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | WELLCOVORIN | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 087439-002 | Oct 19, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
